Is there a company or trademark registered as 'Neurocept' connected to Dr. Paul Cox or Brain Chemistry Labs?
This fact-check may be outdated. Consider refreshing it to get the most current information.
Executive summary
There is no evidence in the supplied reporting that a company or trademark named “Neurocept” is registered to, owned by, or formally connected with Dr. Paul Alan Cox or Brain Chemistry Labs; the available documents describe Dr. Cox’s nonprofit research organization, its team, and clinical work with L‑serine and neurotoxin hypotheses but make no mention of “Neurocept” [1] [2] [3]. That absence in the provided sources does not prove the nonexistence of such a company or trademark elsewhere, only that the supplied reporting does not establish any link.
1. What the sources do establish about Paul Alan Cox and Brain Chemistry Labs
The material supplied repeatedly identifies Paul Alan Cox as an ethnobotanist and executive director of Brain Chemistry Labs / the Institute for EthnoMedicine, outlines his academic pedigree and honors, and describes the nonprofit consortium’s research agenda — notably investigations into cyanobacterial toxin BMAA, L‑serine trials, and clinical collaborations — but none of these pages introduce or reference an entity named “Neurocept” [1] [4] [3] [5] [6].
2. Where “Neurocept” would need to appear to support a connection and what the reporting lacks
A bona fide connection would normally be documented by a company page, trademark filings, press releases, partner announcements, or at least a mention in organizational team or news pages; the Brain Chemistry Labs site and related profiles supplied here contain neither a corporate listing for “Neurocept” nor any trademark data or press statements naming such a firm [2] [7]. The Fortune profile and other third‑party profiles describe Cox’s nonprofit consortium and specific research projects, again without referencing any separate commercial vehicle called Neurocept [6] [8].
3. Claims the sources do make that people sometimes conflate with commercial ventures
The supplied articles emphasize translational aims — for example, Dr. Cox hoping to “secure a diagnostic company partnership” to make tests available to clinicians — language that can be misread or expanded into claims about proprietary companies or trademarks if later reporting or social posts invent names; the Brain Chemistry Labs news blog explicitly mentions the search for partnerships but does not tie that effort to a named commercial entity like “Neurocept” [2]. Fortune’s longform account describes collaborative science and possible therapeutic development but frames that work as originating in a nonprofit consortium rather than in a private, trademarked company [6].
4. What is not covered and the limits of the supplied reporting
The supplied set of documents does not include trademark databases, corporate registry searches, patent filings, or broad media investigations beyond the nonprofit’s own site and profiles of Cox; because those records are absent from the materials provided, it is not possible from these sources alone to categorically confirm that no company or trademark called “Neurocept” exists or that it has never been used in commerce or filings by any party connected to Dr. Cox in some other venue [7] [2]. The proper next step to establish absence would be to search the United States Patent and Trademark Office database, state corporate registries, international trademark databases, and press archives.
5. Alternative explanations and interlocutors to check
A plausible alternative is that “Neurocept” is an unrelated third‑party firm, a product brand name, or a misattribution created by secondary reporting; another possibility is that a commercial entity with that name exists but is not referenced on Brain Chemistry Labs’ public pages because it is independent or was created after the documents supplied here were published [2] [6]. Independent verification would require targeted trademark and corporate record searches and inquiries to Brain Chemistry Labs and Dr. Cox’s office; none of the supplied pages serve as those external validation sources [3] [1].
6. Bottom line and recommended verification steps
Based on the supplied reporting, there is no documented company or trademark “Neurocept” connected to Dr. Paul Cox or Brain Chemistry Labs; that is a negative finding drawn from the absence of any reference across the nonprofit’s website, bios, and the cited profiles [1] [2] [6]. To move from a negative finding to confirmation, consult USPTO and international trademark registries, state business registries, and public press releases or request a direct statement from Brain Chemistry Labs; those searches are beyond the scope of the provided sources and were not available in the materials reviewed [7].